QPS
Trending Articles
Related Content
Ingredients
Developing innovative antivirals for novel viruses
Since the emergence of COVID-19, researchers worldwide have striven to study and overcome this new disease and the novel coronavirus (SARS-CoV-2) that causes it. To achieve this, we will probably need both vaccines and antiviral drugs, report Zamas Lam, Senior Vice President of Preclinical Development, and
John Kolman, Vice President of Translational Medicine, QPS